{"name":"MyoKardia, Inc.","slug":"myokardia-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":146171000,"netIncome":-276213000,"cash":456094000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2022-01-01","label":"Camzyos first approved","drug":"Camzyos","drugSlug":"myk-461","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Camzyos","genericName":"MYK-461","slug":"myk-461","indication":"Obstructive hypertrophic cardiomyopathy (HCM)","status":"marketed"}]}],"pipeline":[{"name":"Camzyos","genericName":"MYK-461","slug":"myk-461","phase":"marketed","mechanism":"Camzyos works by inhibiting the Myosin-7 protein, which is involved in the thickening of heart muscle cells.","indications":["Obstructive hypertrophic cardiomyopathy (HCM)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQZHMtZDBoTERLTFhXRnl1bnZRVDZ4b1R2R1VvVzYyQzliWVpEV1ZkZnhWazlQY3lUSUJlRWNDTHpUMGgyYkd3UUoyT2JKaEdrUmNBT0ZoREVyZnlSbm5qb3pERG9XM213N0VWOWQzaGVSSmZqU0xHVXk1SlZTbmdtNkVMVHA1RmtWc05pcjA0MmNKc3VlSnNNQlp0OXFHZw?oc=5","date":"2025-10-14","type":"pipeline","source":"BioWorld News","summary":"Series B rounds abound with Kardigan’s $254M, Kailera’s $600M - BioWorld News","headline":"Series B rounds abound with Kardigan’s $254M, Kailera’s $600M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOSFpYejhrUTBnY21wQ2lScTh1RGZiRTVfbHlCOU5wQjZ4b2YtMTNtai1HOU1ab2s0c3dhS3RzcG5XSlBESEpnLUxHYlJlb3RSaW14ck9RUVNHTXRTd1NidXJOR1FDQXBEazQ1ZXE4azdJZHdueFpySmNkR2pmT09KNDJmWGMzTFJ0dzFQSTBmUUZHM2VJVDd2TEtYRlJPLVFRV3BnYmZxd0JrMF9z?oc=5","date":"2025-10-14","type":"pipeline","source":"The Business Journals","summary":"Peninsula heart drug company raises $254M with hint of IPO on the horizon - The Business Journals","headline":"Peninsula heart drug company raises $254M with hint of IPO on the horizon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQV3FEWmdvZjBPLXJzMDExQ3hFcFlqcExxcGhWY01NckpIdl9XV1Q1NnA4aE01U1VSVlRtZ2ZLVGZ4M1JZV1R6UVd0WV85T3hvbHNNdDFIMlByZE5RYkRnSjFTTW4yNExpbE5IV2htMmh2Q1dCN2dsWmVBS2puSGxndlU5a280TjRudFZyLTVZMmRIZVZnU1VHNnotZWRQT1FwWFM3ODRiRHFrWVhtb1E?oc=5","date":"2025-03-06","type":"pipeline","source":"The Business Journals","summary":"Why a Big Pharma player is shutting down a Bay Area site, consolidating at another - The Business Journals","headline":"Why a Big Pharma player is shutting down a Bay Area site, consolidating at another","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPZnhONWdLSWdFTWpQWTVwZVFjN3RhYTcxVU4yNlFHQl83NzNrdTFLdHZELUxzel9vbWRwTWdzYlc1eFNGMnRTOHJsMHBLcEN1NjhaVUtzV3F5TWx0b1Q1Zzc3UzJuOW5jajlKTGJ4TDF5XzhRa21pcUIyU2xCOENFc1pZQQ?oc=5","date":"2025-01-10","type":"pipeline","source":"statnews.com","summary":"Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease - statnews.com","headline":"Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxON3hLSXpUWFJHYlZIdkNJUkt1eS1rNkVDclMzVk1nZFMzaEVwUGdPVHZWTjJ2Z21ITlN1UUZ0Z18xZmpQTk1aZXhNNXRYRDAxUjQ1Z0gyVDJfRFp2a2YzVkZjN19TU0oxZlFwMnoxclRtcnNYVnQtVlRIQi1HY2VOVDlfT3ZoVzJ5UUFJaXNhSmhvOWFvODBFbVhrMXRUcTN3Ymc?oc=5","date":"2025-01-10","type":"pipeline","source":"BioSpace","summary":"MyoKardia Alumni Launch Kardigan with $300M to Tackle Heart Disease - BioSpace","headline":"MyoKardia Alumni Launch Kardigan with $300M to Tackle Heart Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPMk9ueGx2TTB2UG1wZTBVdmFRUXpnTDhja1FJR2xyUVFhTnlRUUZnaGZ1Zm9aU3d5eWYySDQ3T3VCY0ItSkE4SXFWaU5icUVpY3llaG9vZmRaQTlVRnMzY1ZPbk5fb19BTHI0SkdNUlNxRTBjbHFXQ0c1bUJZOEFRTEJ0aUZ6RzkxWGtSczRGX1dEdGVJY3dpbldZcnV0c2RTdTFZOTFpTTlGRHZlMDgzQWJBQ0xkbHc4RjVHczVVV2F0Y0MycWc?oc=5","date":"2025-01-10","type":"pipeline","source":"Fierce Biotech","summary":"Kardigan launches with cozy $300M series A and collection of late-stage cardio assets - Fierce Biotech","headline":"Kardigan launches with cozy $300M series A and collection of late-stage cardio assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQM0dFMzgxY2Vud1FBcm4zSDFIVnM1dGpSdjBFc29obE5XUGVaS2JzY0tIU0FFSzllMDYwMEc2WmNJWXZsN2E0eGhYUVdNenYwVjRzYnlRaXA4SXpPZkdMdllHSFZOWmZiQW1veW1rb3NleWZBb3pid1hoVmk5eGtHV0dfSTBrQnBKU1FzeTVxbUsyMDItdU5nQkJpYXBVc1Z4Rmhn?oc=5","date":"2023-12-08","type":"deal","source":"Fierce Pharma","summary":"Bristol Myers Squibb bids farewell to dealmaking czar Elizabeth Mily - Fierce Pharma","headline":"Bristol Myers Squibb bids farewell to dealmaking czar Elizabeth Mily","sentiment":"neutral"},{"date":"2020-11-27","type":"earnings","source":"SEC EDGAR","summary":"SC 13G filed with SEC","headline":"SC 13G Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPalJRNHB0UEdNNmdfdEZvUWViTWZCOXQwVVl5b3pOTUZpMHVOUlV1RXM3bGcySWFKZkRrZk95dEFCbDdwdXBENGpOajUxcFotUUs1cWtKeVVUeXk1ZzFPaFF0ZEdnOVRyNUxVR3lRaGN2akd3NUhBMjFreHljNHRWYk9jVHF0cDVuMGdtdGVDcWV4ZV9XUjlSdDN6SFdaUE5o?oc=5","date":"2020-10-05","type":"deal","source":"Fierce Biotech","summary":"Bristol Myers strikes $13B MyoKardia buyout to gain heart drug - Fierce Biotech","headline":"Bristol Myers strikes $13B MyoKardia buyout to gain heart drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNRkk5RUxwU0swUHd1aFllYXlVSTlVSVJWUzNheTB4NE5TWENzallOQ2JscXRrelJoNEJfNnZTQzNJc2Z0TEF6bE42dnEwUm5LM21DR2lfVURLT2J4WlZjYjBsNjQwZzhNdElCWlBNcmlQeEM0REF1ckdEQUxQNklpdFc1NEJJczhIa0p3SWln?oc=5","date":"2020-10-05","type":"deal","source":"BioPharma Dive","summary":"Bristol Myers to buy MyoKardia in $13B bet on targeted drugs for the heart - BioPharma Dive","headline":"Bristol Myers to buy MyoKardia in $13B bet on targeted drugs for the heart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQ255NjNESnFiTXc4TFNwYjE2QmRablA4YVJiRi1nSzJ1MVdsdl9RVUlJSkdvQzkta3hUSEI4WF9DcXBFN0NWR1pZT3YtSGl3M2MwYl90UUp4OXZEeEdqN1RQaXNNRlZWZEx5Ym55Z1FidTdRZUJHaXdWdE9mRlJwZmtfV0FYNEdIUzJJT1ZrYTFmN2VkdDlRVUtKc0hMT2JJeDF5QlpXUFA4SzF6NmVRVFVVallSNWpfT1l3c0JBejhwS3VIZ0R1ZW16cmdGZGhV?oc=5","date":"2020-10-05","type":"deal","source":"markets.businessinsider.com","summary":"MyoKardia soars 59% after Bristol-Myers agrees to acquire it for $13 billion in cash - markets.businessinsider.com","headline":"MyoKardia soars 59% after Bristol-Myers agrees to acquire it for $13 billion in cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQU1luRTBzTXBhZWtURWdtMmQ0TmR5dUlMbE42SVhTcHZ3bFVYMkpsYWRpOVVBR3dubWZDblgzZnh0SUQ4bjRGd1hocFRwUXRFdFZjejM4VFh3RUVERlduQTBYWE44UFIzbE1OV094eFlTNFg0ZDRrNXF3ZWo2ZzNVWEcxODlVa3pSMUs4TVZUVWwybThWNkk4?oc=5","date":"2020-07-21","type":"pipeline","source":"Contract Pharma","summary":"MyoKardia and Fulcrum Therapeutics Collaborate - Contract Pharma","headline":"MyoKardia and Fulcrum Therapeutics Collaborate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOeUl4UE4wYzdOUEVCSHlNYVZHYWo5RC1XSndkSlRrR1VqWDhhcXRpSHd3b1lHMndhWUtwVzBUTUVwSTVNWXQ3b0lYVzJvVUNaVEdrWE4tajM2ZXA5TGIwNHhSUVdHN2RiNmJ4ZkNPNDBpdDdRdFQ2cFVhM2hWNktjZkFsYXdZNXZSOEw5TlpSbXp1NUk?oc=5","date":"2019-01-02","type":"deal","source":"BioPharma Dive","summary":"Sanofi ends heart drug collaboration with MyoKardia - BioPharma Dive","headline":"Sanofi ends heart drug collaboration with MyoKardia","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":0,"period":"2019-12-31"},{"value":33558000,"period":"2018-12-31"},{"value":33558000,"period":"2018-12-31"},{"value":12400000,"period":"2018-12-31"},{"value":9188000,"period":"2018-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":146171000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-276213000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":456094000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}